Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Inflammatory Bowel Diseases|February 21, 2012
Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel diseaseCasper Steenholdt, Magid Al-khalaf, Jørn Brynskov, et al.
Inflammatory Bowel Diseases|July 29, 2014
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBDMadeline Therese Frederiksen, Mark Andrew Ainsworth, Jørn Brynskov, et al.
BMJ Open|December 20, 2014
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trialSine Schnoor Buhl, Casper Steenholdt, Jørn Brynskov, et al.
Plos One|February 25, 2017
Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalisTania Køllgaard, Christian Enevold, Klaus Bendtzen, et al.
Medicine|April 22, 2016
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn DiseaseCasper Steenholdt, Mehmet Coskun, Sine Buhl, et al.
Journal of Neuroimmunology|May 20, 2009
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1Christian Enevold, Annette Bang Oturai, Per Soelberg Sørensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2010
Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patientsChristian Enevold, Annette B Oturai, Per Soelberg Sørensen, et al.
Therapeutic Drug Monitoring|June 15, 2013
Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's diseaseCasper Steenholdt, Mark A Ainsworth, Michael Tovey, et al.
Infection and Immunity|January 20, 2011
The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytesDaniel Belstrøm, Palle Holmstrup, Christian Damgaard, et al.
Genes|May 25, 2024
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational StudyPaolo Fagone, Katia Mangano, Maria Sofia Basile, et al.
Pageof 11